Case Study : USFDA approval of Vosevi for Hepatitis C
The U.S. Food and Drug Administration has approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis... Read More
Biocon launched Gilead Sciences’ Hepatitis C drug – CIMIVIR-L in India
BIopharmaceutical company Biocon on Thursday said it has launched a generic version of Gilead Sciences’ Hepatitis C drug, Harvoni, in India. The... Read More